CSL Limited (ASX:CSL) investors shrugged off the company’s hefty loss, instead focusing on stronger-than-expected FY27 earnings guidance, while Brookfield’s improved bid has put Reliance back in the spotlight.
CSL shares jumped 15% to $154.43 in the opening minutes of trade. By midday, shares were 16.71% higher.
Ahead of the market open, RBC Capital Markets analyst Craig Wong-Pan said CSL had “delivered a good FY26 result with beats across revenue, EBITDA and NPATA”.
“Compositionally, all segments exceeded revenue and gross profit expectations,” Wong-Pan said.
He calculated CSL’s guidance as implying FY27 constant-currency profit of about US$2.98 billion and underlying NPAT of around US$2.93 billion.
“The stock has had a strong run into this result, however we expect the FY27 guidance beat to consensus and strong Ig performance in 2H26 to drive outperformance in the stock today,” Wong-Pan said.